Analyse court terme - DSM : Les prix dépassent la moyenne mobile, c'est un signal de force.
La tendance est toujours haussière mais elle a ralenti. Son niveau d'invalidation est sous 56,40 €. L'objectif est à 64,21 €.Arguments :
- La résistance est atteinte, la réaction des prix est insuffisante pour modifier notre avis.
- Le MACD n'est pas en zone de surachat.
- Les...
Royal DSM is engaged in the creation of products and services in Life Sciences and Materials Sciences. Co.'s products and services are used globally in range of markets and applications in healthcare, pharmaceutical automotive and chemicals sectors. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. The activities of Co. are grouped into four clusters: Nutrition, Pharma, Performance Materials and Polymer Intermediates.
DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.